InvestorsHub Logo
Followers 2
Posts 26
Boards Moderated 0
Alias Born 10/19/2023

Re: beartrap12 post# 703147

Monday, 07/01/2024 9:13:48 PM

Monday, July 01, 2024 9:13:48 PM

Post# of 703303
Thank you for the kind words beartrap12! I agree with your points about NICE's involvement. The data collection and the proactive approach from NICE show their commitment to helping NWBO navigate the pricing process for DCVax-L. Given the significant interest from the brain cancer community and the potential benefits for patients, it's clear that Great Britain is eager to see this treatment approved. At this point, the only fitting response to any skepticism is "let's see," as all signs indicate a strong push towards making DCVax-L commercially available.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News